The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Stocks Up; Powell To Make Jackson Hole Debut

Fri, 24th Aug 2018 11:54

LONDON (Alliance News) - Stocks in London were marginally higher at midday on Friday ahead of a highly anticipated speech from the head of the US Federal Reserve.With US-China trade talks demoting a lack of significant progress, investors will now shift focus to a speech by Federal Reserve Chairman Jerome Powell in the afternoon for fresh updates on the outlook for the US economy. Investors also adopted a cautious stance ahead of the long bank holiday weekend in the UK.The FTSE 100 index was up 0.1%, or 10.10 points at 7,573.32. The FTSE 250 was up 0.2%, or 31.14 points, at 20,696.00, and the AIM All-Share was down 0.3%, or 3.69 points, at 1,088.86.The Cboe UK 100 was up 0.1% at 12,831.08, the Cboe UK 250 was up 0.1% at 18,783.21, and the Cboe UK Small Companies was up 0.1% at 12,342.86.On the London Stock Exchange, Antofagasta was the best blue chip performer, up 3.2% after RBC Capital upgraded the Chilean copper miner to Outperform from Sector Perform. Shire was up 2.2% after the US Food & Drug Administration has approved the Irish pharmaceutical company's Takhzyro drug to treat a rare genetic disease. The disease, hereditary angioedema, causes attacks of swelling in different parts of the body and can be life-threatening. Approval from the FDA follows a phase III study of 125 patients in which Takhzyro reduced monthly attacks by, on average, 87% in patients when compared with a placebo.Miners were also higher with Anglo American, up 1.6%, Rio Tinto, up 1.1%, BHP Billiton, up 1.1%. "A rebound in copper, platinum and palladium has helped mining stocks. The cooling of the Chinese economy has triggered major volatility in the metals market, as investors are worried about future demand. For the time being, the size of the tariffs being imposed on Chinese goods imported into the US are relatively small, but if it is drawn out, it could chip away at growth," said David Madden, market analyst at CMC Markets.Conversely, housebuilders were weighing on the large cap index amid a decline in UK mortgage approval figures in July.Berkeley Group was down 1.8%, Barratt Developments, down 1.6%, Persimmon, down 1.1%, Taylor Wimpey, down 1.0%.The number of mortgages approved in July fell to 39,584 from 40,330 in June. Economists had forecast approvals to rise to 40,650, data from UK Finance showed. "Housebuilders have taken a knock as a double whammy of lower new approved mortgages and a five-month low in mortgage lending weighed on the sector," IG Group analyst Chris Beauchamp said. Additionally, midcap peers McCarthy & Stone, Bovis Homes and Bellway were down 1.6%, 1.4% and 0.9%, respectively. Sterling was quoted at USD1.2823 at midday, compared to USD1.2830 at the London equities close on Thursday. The pound was flat with investors unmoved by new details covering a "no deal" Brexit unveiled by Brexit Secretary Dominic Raab on Thursday. In mainland Europe, the CAC 40 in Paris was up 0.5% while the DAX 30 in Frankfurt was up 0.2%.The euro was flat against the dollar quoted at USD1.1565 at midday, from USD1.1569 at the European equities close Thursday, following solid Germany GDP data. Germany's economy expanded at a faster pace as initially estimated on domestic demand in the second quarter, detailed data from Destatis showed.The largest euro area economy grew 0.5% sequentially, following the 0.4% increase in the first quarter. The rate came in line with the estimate released on August 14.On a yearly basis, gross domestic product advanced at a faster pace of 2.3% after expanding 1.4% a quarter ago. Meanwhile, the calendar-adjusted GDP growth slowed slightly to 2% from 2.1%. Both annual rates matched expectations.Stocks in New York were set for a higher open as Fed Chair Powell gets set to take the stage at the Economic Policy Symposium in Jackson Hole.The DJIA, the S&P 500 index and the Nasdaq Composite were all called up 0.2%.Powell will make his maiden address to some of the world's most prominent central bankers at the gathering in Wyoming at 1500 BST, a week after US President Donald Trump took aim at the Fed chair.Earlier this week, the Fed has pencilled in two more interest rate hikes this year despite risks from trade conflicts and emerging market turmoil.In response, Trump reiterated his criticism of the Fed's monetary policy, saying he was "not thrilled" with the central bank for raising interest rates and that it should do more to help boost the US economy. It remains to be seen whether Powell will respond to Trump's criticism.Powell was hand picked by Trump to lead the US central bank.
More News
14 Sep 2018 09:15

Shire gains as takeover approved by China

(Sharecast News) - Japan's Takeda Pharmaceutical has received regulatory approval from China for its $62bn takeover of London-listed Shire.

Read more
13 Sep 2018 10:56

Takada eyeing potential Shire asset sales to pay down debt

(Sharecast News) - Takeda Pharmaceutical may try and sell Shire's dry-eye drug once it completes the $62bn takeover purchase of the UK-listed biotech, according to a report on Thursday.

Read more
13 Sep 2018 08:25

Takeda weighs sale of Shire's eye care business to cut debt- Bloomberg

Sept 13 (Reuters) - Japan's Takeda Pharmaceutical is considering selling Shire Plc's eye care business once it closes its $62 billion purchase of the London-listed drugmaker, as it looks a

Read more
12 Sep 2018 16:12

Takeda to pack up Illinois HQ, nearly 1,000 workers to be affected

Sept 12 (Reuters) - Japan's Takeda Pharmaceutical Co Ltd said on Wednesday it plans to shut its U.S. headquarters in Deerfield, Illinois and move it to the greater Boston area, following the —

Read more
12 Sep 2018 07:22

Shire gets EC marketing authorisation for 'VEYVONDI' treatment

(Sharecast News) - Rare diseases specialist Shire announced on Wednesday that the European Commission has granted marketing authorisation for 'VEYVONDI', for the treatment of bleeding events and the treatment and prevention of surgical bleeding in adults with von Willebrand disease, when desmopressin treatment alone is ineffective or not indicated.

Read more
10 Sep 2018 16:08

Two Shire Subsidiaries Receive Majority Early Offers For Senior Notes

LONDON (Alliance News) - Biotechnology company Shire PLC on Monday said two of its subsidiaries, Baxalta Inc and Shire Acquisitions Investments Ireland DAC, had received early offers for a of the

Read more
7 Sep 2018 09:33

BROKER RATINGS SUMMARY: Goldman Cuts Burberry; Redburn Cuts HSBC

LONDON (Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:----------FTSE 100----------GOLDMAN CUTS GROUP TO BUY -

Read more
6 Sep 2018 11:20

European Shares Reverse Early Losses On Improving Sentiment

BRUSSELS/FRANKFURT/PARIS (Alliance News) - European stocks were marginally higher on Thursday after having fallen to a five-month low earlier in the day.Sentiment improved somewhat after US

Read more
6 Sep 2018 10:54

TOP NEWS: Shire Buys Swiss Plasma Collection Firm Sanaplasma

LONDON (Alliance News) - Shire PLC said Thursday it has bought Swiss source plasma collection company sanaplasma AG for an undisclosed sum.The FTSE 100 pharmaceutical giant said that the is

Read more
6 Sep 2018 10:52

Shire buys Swiss plasma firm sanaplasma for undisclosed sum

(Sharecast News) - Pharmaceuticals giant Shire on Thursday said it had bought Switzerland's sanaplasma AG for an undisclosed sum.

Read more
6 Sep 2018 07:48

UPDATE 1-UK Stocks-Factors to watch on Sept. 6

Sept 6 (Reuters) - Britain's FTSE 100 futures were down 0.1 percent ahead of the cash market open on Thursday. * DIXONS CARPHONE: Dixons Carphone, the troubled British electricals and a

Read more
31 Aug 2018 10:16

Shire Completes USD2.4 Billion Oncology Franchise Sale To Servier

LONDON (Alliance News) - Irish biotechnology giant Shire PLC said Friday it has completed the sale of its oncology franchise to Servier SAS.The FTSE 100-listed company sold its franchise, a

Read more
31 Aug 2018 09:07

Shire completes $2.4bn oncology sale to Servier

(Sharecast News) - Shire has completed the sale of its oncology franchise to Servier for $2.4bn, it announced on Friday.

Read more
24 Aug 2018 14:04

TOP NEWS: Shire Launches Tender Offer To Buy Up To USD2 Billion Notes (ALLISS)

LONDON (Alliance News) - Biotechnology company Shire PLC on Friday said its wholly-owned subsidiaries Baxalta and Shire Acquisitions Investments Ireland DAC launched a tender offer to repurchase a

Read more
24 Aug 2018 13:54

MARKET ANALYSIS: Futures Pointing To Initial Strength On Wall Street

WASHINGTON (Alliance News) - The major US index futures are pointing to a higher opening on Friday, with stocks likely to move to the upside after ending the previous session modestly upward on a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.